BioSpace News Archive

Business

Biogen to Report Fourth Quarter and Year-End 2017 Financial Results on January 25, 2018

Biogen announced it will report fourth quarter and year-end 2017 financial results on Thursday, January 25, 2018, before the financial markets open.

December 20, 2017

·

1 min read

Genetown

Insulet Corporation to Present at Upcoming Investor Conference on January 9

Insulet Corporation announced that management will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, California on January 9, 2018, at 4:30pm (Pacific Time).

December 20, 2017

·

2 min read

FDA

FDA Approves Genentech’s Perjeta (pertuzumab) for Adjuvant Treatment of Specific Type of Early Breast Cancer

Genentech announced the FDA has approved Perjeta (pertuzumab), in combination with Herceptin® (trastuzumab) and chemotherapy (the Perjeta-based regimen).

December 20, 2017

·

13 min read

Business

Advaxis Reports Fiscal Year 2017 Financial Results and Provides a Business Update

As of October 31, 2017, Advaxis had cash, cash equivalents and investments of $70.9 million.

December 20, 2017

·

7 min read

BioMidwest

Life Spine Announces Initial Cases and Multiple Surgeries With the SIMPACT Tri-Fin Sacroiliac Joint Fusion System

SIMPACT Tri-Fin, which features OSSEO-LOC surface technology, launched November of 2017 and joins Life Spine’s broad portfolio of full procedural solutions.

December 20, 2017

·

1 min read

Pharm Country

Oncoceutics Extends Composition of Matter Patent Portfolio to ONC212

Oncoceutics announced that the USPTO issued patent #9,845,324, providing the company with composition of matter protection for ONC212 and several additional small molecules derived from Oncoceutics’ lead compound ONC201.

December 20, 2017

·

3 min read

Business

Avivagen Announces Results for Fiscal Year Ending October 31, 2017

Avivagen today reported its audited financial results for the year ended October 31, 2017 and provided highlights of its fiscal 2018 objectives. Unless otherwise noted, all figures are in Canadian currency.

December 20, 2017

·

6 min read

Business

New Member Appointed to the Board of Directors of Neuralstem

Dr. Chen was appointed by Tianjin to replace Zhang Zhuo as the director appointee of the Series A Convertible Preferred Stock.

December 20, 2017

·

3 min read

Business

ImmunoPrecise Adds Scientific Depth to its Board of Directors

ImmunoPrecise is pleased to announce the appointment of Dr. Robert Burke to the Company’s Board of Directors.

December 20, 2017

·

4 min read

Drug Development

Allergan Release: FDA Accepts NDA for Seysara (Sarecycline) for the Treatment of Moderate to Severe Acne

Allergan and Paratek Pharma today announced that the FDA has accepted a NDA to review Seysara for the treatment of moderate to severe acne vulgaris in patients 9 years of age and older.

December 20, 2017

·

8 min read